Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Integrating the Biomarker Copeptin Into the Process of Managing Patients With Suspected ACS

NCT01498731 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT01498731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01498731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Integrating the Biomarker Copeptin Into the Process of Managing Patients With Suspected ACS
Lead sponsor
Charite University, Berlin, Germany
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2011
Completion date
June 30, 2013
Enrollment
902 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction